List of Ethris patents

List of Ethris patents

List of Genesys (company) patents

List of Applied Biotechnology Institute, Inc. patents

List of Ondax Inc. patents

List of space operations management patents

List of SBIR/STTR awards granted to Seagull Technology, Inc.

Patents where

Current Assignee

Name

is

Ethris

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11136585 UTRs increasing the translation efficiency of RNA molecules	Patent 11136585 was granted and assigned to ethris GmbH on October, 2021 by the United States Patent and Trademark Office.	Ethris	Ethris		United States Patent and Trademark Office	11136585	October 5, 2021
	‌ US Patent 11981910 Minimal UTR sequences	Patent 11981910 was granted and assigned to ethris GmbH on May, 2024 by the United States Patent and Trademark Office.	Ethris	Ethris		United States Patent and Trademark Office	11981910	May 14, 2024
	‌ US Patent 11352638 Minimal UTR sequences	Patent 11352638 was granted and assigned to ethris GmbH on June, 2022 by the United States Patent and Trademark Office.	Ethris	Ethris		United States Patent and Trademark Office	11352638	June 7, 2022
	‌ US Patent 12064484 Compositions for introducing RNA into cells	Patent 12064484 was granted and assigned to ethris GmbH on August, 2024 by the United States Patent and Trademark Office.	Ethris	Ethris		United States Patent and Trademark Office	12064484	August 20, 2024
	‌ US Patent 10272161 RNA for use in the treatment of ligament or tendon lesions	Patent 10272161 was granted and assigned to ethris GmbH on April, 2019 by the United States Patent and Trademark Office.	Ethris	Ethris		United States Patent and Trademark Office	10272161	April 30, 2019
	‌ US Patent 11020487 Compositions for introducing nucelic acid into cells	Patent 11020487 was granted and assigned to ethris GmbH on June, 2021 by the United States Patent and Trademark Office.	Ethris	Ethris		United States Patent and Trademark Office	11020487	June 1, 2021
	‌ US Patent 11065346 RNA for use in the treatment of ligament or tendon lesions	Patent 11065346 was granted and assigned to ethris GmbH on July, 2021 by the United States Patent and Trademark Office.	Ethris	Ethris		United States Patent and Trademark Office	11065346	July 20, 2021
	‌ US Patent 10080804 Conjugate with target-finding ligand and use thereof	Patent 10080804 was granted and assigned to ethris GmbH on September, 2018 by the United States Patent and Trademark Office.	Ethris	Ethris		United States Patent and Trademark Office	10080804	September 25, 2018
	‌ US Patent 11479768 ATP-binding cassette family coding polyribonucleotides and formulations thereof		Ethris	Ethris		United States Patent and Trademark Office	11479768	October 25, 2022
	‌ US Patent 9555122 Conjugate with target-finding ligand and use thereof	Patent 9555122 was granted and assigned to ethris GmbH on January, 2017 by the United States Patent and Trademark Office.	Ethris	Ethris		United States Patent and Trademark Office	9555122	January 31, 2017
	‌ US Patent 10927383 Cas9 mRNAs	Patent 10927383 was granted and assigned to ethris GmbH on February, 2021 by the United States Patent and Trademark Office.	Ethris	Ethris		United States Patent and Trademark Office	10927383	February 23, 2021
	‌ US Patent 10583195 Conjugate with target-finding ligand and use thereof	Patent 10583195 was granted and assigned to ethris GmbH on March, 2020 by the United States Patent and Trademark Office.	Ethris	Ethris		United States Patent and Trademark Office	10583195	March 10, 2020
	‌ US Patent 11104887 Ornithine transcarbamylase coding polyribonucleotides and formulations thereof	Patent 11104887 was granted and assigned to ethris GmbH on August, 2021 by the United States Patent and Trademark Office.	Ethris	Ethris		United States Patent and Trademark Office	11104887	August 31, 2021
	‌ US Patent 8871230 Conjugate with target-finding ligand and use thereof	Patent 8871230 was granted and assigned to ethris GmbH on October, 2014 by the United States Patent and Trademark Office.		Ethris		United States Patent and Trademark Office	8871230	October 28, 2014
	‌ US Patent 10745698 RNA with a combination of unmodified and modified nucleotides for protein expression		Ethris	Ethris		United States Patent and Trademark Office	10745698	August 18, 2020
	‌ US Patent 8567410 Magnet-field controlled active substance transfer for aerosol therapy	Patent 8567410 was granted and assigned to ethris GmbH on October, 2013 by the United States Patent and Trademark Office.		Ethris		United States Patent and Trademark Office	8567410	October 29, 2013

16 results

0 selected

16 results

0 selected